Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jul 14, 2022; 28(26): 3218-3231
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3218
Figure 1
Figure 1 Kaplan-Meier–overall survival: Time to delisting or death on waitlist. A: Ascites adjusted body mass index (BMI) groups (non-transplanted patients only); B: Ascites adjusted BMI and frailty (full cohort); C: Ascites adjusted BMI and frailty (non-transplanted patients only). HR: Hazard ratio; BMI: Body mass index.
Figure 2
Figure 2 Competing risk analysis for time to transplant. A: Ascites adjusted body mass index (BMI) groups; B: Ascites adjusted BMI and frailty. HR: Hazard ratio; BMI: Body mass index.
Figure 3
Figure 3 Change in body mass index from time of listing to post liver transplant at 1 and 5 yr. BMI: Body mass index.
Figure 4
Figure 4 Kaplan-Meier–overall survival: Time to death post liver transplant stratified by ascites adjusted body mass index groups. Lower panel shows the 1- and 5-yr survival estimates. HR: Hazard ratio; BMI: Body mass index.